- US12419843utility2025Method for Preparing a Solid Dosage Form Comprising Antibodies by Wet Granulation, Extrusion and Spheronization0 cites
- US12370146utility2025Method of Producing a Delayed Release Drug Formulation0 cites
- US12370147utility2025Coatable Core for a Modified Release Drug Formulation0 cites
- US12215146utility2025Antibody Variants0 cites
- US12209122utility2025Anti-tnf-alpha-antibodies and Functional Fragments Thereof0 cites
- US12043663utility2024Anti-tnf-alpha-antibodies and Functional Fragments Thereof0 cites
- US11999781utility2024Antibody Variants0 cites
- US11998641utility2024Modified Release Coated Capsules0 cites
- US11826470utility2023Preparation of Solid Dosage Forms Comprising Antibodies by Solution/suspension Layering0 cites